Meena B Bansal, MD
img_Meena B Bansal
PROFESSOR | Medicine, Liver Diseases
Are you a patient?
Gastroenterology, Liver Transplantation
Research Topics
AIDS/HIV, Cell Biology, Chemokines, Fibrosis, Hepatitis C Virus, Knockout Mice, Molecular Biology, Regeneration, Transcription Factors, Transcriptional Activation and Repression, Viruses and Virology
Multi-Disciplinary Training Area
Cancer Biology [CAB], Disease Mechanisms and Therapeutics (DMT)
Specific Clinical/Research Interests: Role of chemokine receptors, CXCR4 and CCR5, on stellate cell biology and fibrogenesis; molecular regulation of hepatic fibrosis and regeneration

Current Students: Yedidya Saiman

Postdoctoral Fellows: Ana Tuyama; Ritu Agarwal

Research Personnel: Feng Hong

Summary of Research Studies:
Brief Biosketch and Research Interests Dr. Bansal joined the faculty at Mount Sinai in 2001 after completing Gastroenterology Fellowship at the University of Pennsylvania. In 2002 she became the Hepatology Fellowship Director, leading one of the largest hepatology fellowships in the United States. While remaining clinically active, she has also developed an NIH-funded basic research program focusing on understanding underlying molecular mechanisms of liver fibrosis/cirrhosis in an effort to develop novel anti-fibrotic therapies. Her research interests focus on the role of Matrix Metalloproteinase-2 in liver fibrosis and regeneration and Role of the chemokine receptors, CXCR4 and CCR5, on stellate cell biology and fibrogenesis. The latter has great implications in understanding mechanism of HCV- and HIV/HCV-induced liver disease.
Metabolic Dysfunction-Associated Steatohepatitis (MASH), Molecular Mechanisms of Liver Fibrosis, Liver Disease in patients living with HIV
Research Team: Vikram Sivakumar Alejandra Paredes Anna Mageras Mark Miller Julia Napoli Rohit Nathani Jake Debroff Rabab Oun Ali Anwar Alyssa Chen

AB, Harvard University

MD, Cornell University Medical College

MD, Weill Medical College of Cornell University

The New York Hospital-Cornell Medical Center

Residency, Internal Medicine, New York Presbyterian Hospital-Weill Cornell Center

Fellowship, Gastroenterology, Hospital of the University of Pennsylvania


Am Bd of Obesity Medicine
American Board of Internal Medicine


Achievement Awardee at American Association of Physicians of Indian Origin (AAPI-Queens/LI) Annual Gala


Achievement Honoree at RANA (Rajasthan Association of North America) Annual Awards Gala


Dr. Harold and Golden Lamport Research Award

Regal Awards: Research Excellence in GI and Liver


First Prize

Komarov Competition-Basic Science. Philadelphia, Pennsylvania


David E. Rogers Memorial Prize

The New York Hospital-Cornell University Medical College


C. Richard Bowman Memorial Award

The New York Hospital-Cornell University Medical College

Miles and Shirley Fiterman Basic Research Award

American Gastroenterological Association

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Bansal during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Merck Pharmaceuticals
  • GSK plc.
  • Novo Nordisk
  • The Kinetix Group
  • Madrigal
  • Intercept Pharm

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.